Exclusion of IL-21 in the pathogenesis of OVA-induced asthma in mice

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 10, 2014, Pages 3202-3208

  Cheng, Sheng ^a   Chen, Huilong ^a   Wang, Aili ^a   Bunjhoo, Hansvin ^a   Cao, Yong ^a   Xie, Jungang ^a   Xu, Yongjian ^a   Xiong, Weining ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Allergic lung inflammation; Asthma; Challenge; Cytokine; Interleukin 21

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 21;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HISTOPATHOLOGY; LUNG LAVAGE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; NOSE MUCOSA; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; PATHOGENESIS;

EID: 84910023656     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-281.
2. Kuperman D, Schofield B, Wills-Karp M, Grusby MJ. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 1998; 187: 939-948.
3. Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2263.
4. Cohn L, Homer RJ, MacLeod H, Mohrs M, Brombacher F, Bottomly K. Th2-Induced Airway Mucus Production Is Dependent on IL-4Rα, But Not on Eosinophils. J Immunol 1999; 162: 6178-6183.
5. Mojtabavi N, Dekan G, Stingl G, Epstein MM. Long-Lived Th2 Memory in experimental allergic asthma. J Immunol 2002; 169: 4788-4796.
6. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
7. Wang Y, Voo KS, Liu B, Chen C, Uygungil B, Spoede W, Bernstein JA, Huston DP, Liu Y. A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 2010; 207: 2479-2491.
8. Chakir J, Shannon J, Molet S, Fukakusa M, Elias J, Laviolette M, Boulet L, Hamid Q. Airway remodeling-associated mediators in moderate to severe asthma: Effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immun 2003; 111: 1293-1298.
9. Parrish-Novak J, Foster DC, Holly RD, Clegg CH. Interleukin-21 and the IL-21 receptor: novel effectors of NK and T cell responses. J Leukocyte Biol 2002; 72: 856-863.
10. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008; 26: 57-79.
11. Jin H, Carrio R, Yu A, Malek TR. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or bim-dependent apoptosis. J Immunol 2004; 173: 657-665.
12. Ozaki K, Spolski R, Ettinger R, Kim H, Wang G, Qi C, Hwu P, Shaffer DJ, Akilesh S, Roopenian DC, Morse HC, Lipsky PE, Leonard WJ. Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-6. J Immunol 2004; 173: 5361-5371.
13. Liu R, Wu Q, Su D, Che N, Chen H, Geng L, Chen J, Chen W, Li X, Sun L. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis. Arthritis Res Ther 2012; 14: R255.
14. Raveney BJE, Oki S, Yamamura T. Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling. PLoS One 2013; 8: e56595.
15. Terrier B, Geri G, Chaara W, Allenbach Y, Rosenzwajg M, Costedoat-Chalumeau N, Fouret P, Musset L, Benveniste O, Six A, Klatzmann D, Saadoun D, Cacoub P. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis. Arthritis Rheum 2012; 64: 2001-2011.
16. Petrella TM, Tozer R, Belanger K, Savage KJ, Wong R, Smylie M, Kamel-Reid S, Tron V, Chen BE, Hunder NN, Hagerman L, Walsh W, Eisenhauer EA. Interleukin-21 has activity in patients with metastatic melanoma: a phase II study. J Clin Oncol 2012; 30: 3396-3401.
17. Souza AP, Bonorino C, Muraro SP, Rodrigues Jr LC. Interleukin-21 expanded NKDC in vitro reduces the B16F10 tumor growth in vivo. Cytokine 2013; 61: 154-160.
18. Santegoets S, Turksma A, Suhoski M, Stam A, Albelda S, Hooijberg E, Scheper R, van den Eertwegh A, Gerritsen W, Powell D, June C, de Gruijl T. IL-21 promotes the expansion of CD27+CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells. J Transl Med 2013; 11: 37.
19. Konforte D, Simard N, Paige CJ. IL-21: an executor of B cell fate. J Immunol 2009; 182: 1781-1787.
20. Hiromura Y, Kishida T, Nakano H, Hama T, Imanishi J, Hisa Y, Mazda O. IL-21 administration into the nostril alleviates murine allergic rhinitis. J Immunol 2007; 179: 7157-7165.
21. Chatterjee R, Batra J, Ghosh B. A common exonic variant of interleukin21 confers suscepti bility to atopic asthma. Int Arch Allergy Immunol 2009; 148: 137-146.
22. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, Biswal S. Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 2005; 202: 47-59.
23. Jin H, Oyoshi MK, Le Y, Bianchi T, Koduru S, Mathias CB, Kumar L, Le Bras S, Young D, Collins M, Grusby MJ, Wenzel J, Bieber T, Boes M, Silberstein LE, Oettgen HC, Geha RS. IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J Clin Invest 2009; 119: 47-60.
24. Frohlich A, Marsland BJ, Sonderegger I, Kurrer M, Hodge MR, Harris NL, Kopf M. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 2007; 109: 2023-2031.
25. Lajoie S, Lewkowich I, Herman NS, Sproles A, Pesce JT, Wynn TA, Grusby MJ, Hamid Q, Wills-Karp M. IL-21 receptor signalling partially mediates Th2-mediated allergic airway responses. Clin Exp Allergy 2014; 44: 976-985.
26. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008; 26: 57-79.
27. Vogelzang A, McGuire HM, Liu SM, Gloss B, Mercado K, Earls P, Dinger ME, Batten M, Sprent J, King C. IL-21 contributes to fatal inflammatory disease in the absence of Foxp3+ T regulatory cells. J Immunol 2014; 192: 1404-1414.
28. Monteleone G, Pallone F, MacDonald TT. Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses. Trends Immunol 2008; 29: 290-294.
29. Spolski R, Leonard WJ. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Opin Immunol 2008; 20: 295-301.
30. Suto A, Nakajima H, Hirose K, Suzuki K, Kagami S, Seto Y, Hoshimoto A, Saito Y, Foster DC, Iwamoto I. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cepsilon transcription of IL-4-stimulated B cells. Blood 2002; 100: 4565-4573.
31. Caven TH, Shelburne A, Sato J, Chan-Li Y, Becker S, Conrad DH. IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell Immunol 2005; 238: 123-134.
32. Magari M, Nishikawa Y, Fujii Y, Nishio Y, Watanabe K, Fujiwara M, Kanayama N, Ohmori H. IL-21-dependent B Cell Death Driven by Prostaglandin E2, a Product Secreted from Follicular Dendritic Cells. J Immunol 2011; 187: 4210-4218.